Literature DB >> 18305046

Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus.

R Santarelli1, A Farina, M Granato, R Gonnella, S Raffa, L Leone, R Bei, A Modesti, L Frati, M R Torrisi, A Faggioni.   

Abstract

We report the identification and characterization of p33, the product of Kaposi's sarcoma-associated herpesvirus (KSHV) open reading frame 69 (ORF69), a positional homolog of the conserved herpesvirus protein UL31. p33 is expressed upon induction of viral lytic cycle with early kinetics. Immunofluorescence analysis revealed that in infected cell lines, the protein is localized in the nucleus, both in dotted spots and along the nuclear membrane. Nuclear fractionation experiments showed that p33 partitions with the nuclear matrix, and both immunoblotting of purified virions and immunoelectron microscopy indicated that the novel protein is not a component of the mature virus. Following ectopic expression in KSHV-negative cells, the protein was never associated with the nuclear membrane, suggesting that p33 needs to interact with additional viral proteins to reach the nuclear rim. In fact, after cotransfection with the ORF67 gene, the KSHV positional homolog of UL34, the p33 intranuclear signal changed and the two proteins colocalized on the nuclear membrane. A similar result was obtained when ORF69 was cotransfected with BFRF1, the Epstein-Barr virus (EBV) positional homolog of UL34 and ORF67. Finally, upon cotransfection, ORF69 significantly increased nuclear membrane reduplications induced by BFRF1. The above results indicate that KSHV p33 shares many similarities with its EBV homolog BFLF2 and suggest that functional cross-complementation is possible between members of the gammaherpesvirus subfamily.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305046      PMCID: PMC2293072          DOI: 10.1128/JVI.02400-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  The nuclear lamina comes of age.

Authors:  Yosef Gruenbaum; Ayelet Margalit; Robert D Goldman; Dale K Shumaker; Katherine L Wilson
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

2.  The null mutant of the U(L)31 gene of herpes simplex virus 1: construction and phenotype in infected cells.

Authors:  Y E Chang; C Van Sant; P W Krug; A E Sears; B Roizman
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress.

Authors:  Antonella Farina; Regina Feederle; Salvatore Raffa; Roberta Gonnella; Roberta Santarelli; Luigi Frati; Antonio Angeloni; Maria Rosaria Torrisi; Alberto Faggioni; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase.

Authors:  Shane C McAllister; Scott G Hansen; Ilhem Messaoudi; Janko Nikolich-Zugich; Ashlee V Moses
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.

Authors:  G Miller; L Heston; E Grogan; L Gradoville; M Rigsby; R Sun; D Shedd; V M Kushnaryov; S Grossberg; Y Chang
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir.

Authors:  Michael Lu; Jacqueline Suen; Carolina Frias; Ruth Pfeiffer; Mong-Hsun Tsai; Eric Chuang; Steven L Zeichner
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  AIDS-related malignancies.

Authors:  Chris Boshoff; Robin Weiss
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

8.  Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies.

Authors:  L Zhu; V Puri; B Chandran
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

9.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.

Authors:  D M Lukac; R Renne; J R Kirshner; D Ganem
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.

Authors:  R Renne; W Zhong; B Herndier; M McGrath; N Abbey; D Kedes; D Ganem
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

View more
  27 in total

Review 1.  Breach of the nuclear lamina during assembly of herpes simplex viruses.

Authors:  Lynda A Morrison; Gregory S DeLassus
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

2.  The Human Cytomegalovirus Transmembrane Protein pUL50 Induces Loss of VCP/p97 and Is Regulated by a Small Isoform of pUL50.

Authors:  Myoung Kyu Lee; Seokhwan Hyeon; Jin-Hyun Ahn
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Reconstitution of the Kaposi's sarcoma-associated herpesvirus nuclear egress complex and formation of nuclear membrane vesicles by coexpression of ORF67 and ORF69 gene products.

Authors:  Prashant J Desai; Erin N Pryce; Brandon W Henson; Eric M Luitweiler; Jonathan Cothran
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Analysis of a charge cluster mutation of herpes simplex virus type 1 UL34 and its extragenic suppressor suggests a novel interaction between pUL34 and pUL31 that is necessary for membrane curvature around capsids.

Authors:  Richard J Roller; Susan L Bjerke; Alison C Haugo; Sara Hanson
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

Review 5.  Herpesvirus interactions with the host cytoskeleton.

Authors:  Mathew G Lyman; Lynn W Enquist
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Intragenic and extragenic suppression of a mutation in herpes simplex virus 1 UL34 that affects both nuclear envelope targeting and membrane budding.

Authors:  Richard J Roller; Alison C Haugo; Nora J Kopping
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

7.  Mechanism of Nuclear Lamina Disruption and the Role of pUS3 in HSV-1 Nuclear Egress.

Authors:  Masoudeh Masoud Bahnamiri; Richard J Roller
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

8.  Herpes simplex virus 1 pUL34 plays a critical role in cell-to-cell spread of virus in addition to its role in virus replication.

Authors:  Alison C Haugo; Moriah L Szpara; Lance Parsons; Lynn W Enquist; Richard J Roller
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

9.  KSHV reduces autophagy in THP-1 cells and in differentiating monocytes by decreasing CAST/calpastatin and ATG5 expression.

Authors:  R Santarelli; M Granato; G Pentassuglia; V Lacconi; M S Gilardini Montani; R Gonnella; M Tafani; M R Torrisi; A Faggioni; M Cirone
Journal:  Autophagy       Date:  2016-10-07       Impact factor: 16.016

10.  Tracking expression and subcellular localization of RNA and protein species using high-throughput single cell imaging flow cytometry.

Authors:  Sumit Borah; Lisa A Nichols; Lynn M Hassman; Dean H Kedes; Joan A Steitz
Journal:  RNA       Date:  2012-06-28       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.